{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:45:29Z","timestamp":1792806329289,"version":"4.5.0"},"reference-count":109,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82403500"],"award-info":[{"award-number":["82403500"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China","award":["BK20241040"],"award-info":[{"award-number":["BK20241040"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China","award":["1020241241"],"award-info":[{"award-number":["1020241241"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Jiangsu Province","award":["82403500"],"award-info":[{"award-number":["82403500"]}]},{"name":"Natural Science Foundation of Jiangsu Province","award":["BK20241040"],"award-info":[{"award-number":["BK20241040"]}]},{"name":"Natural Science Foundation of Jiangsu Province","award":["1020241241"],"award-info":[{"award-number":["1020241241"]}]},{"name":"Natural Science Fund for Colleges and Universities in Jiangsu Province","award":["82403500"],"award-info":[{"award-number":["82403500"]}]},{"name":"Natural Science Fund for Colleges and Universities in Jiangsu Province","award":["BK20241040"],"award-info":[{"award-number":["BK20241040"]}]},{"name":"Natural Science Fund for Colleges and Universities in Jiangsu Province","award":["1020241241"],"award-info":[{"award-number":["1020241241"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Tanshinone IIA (T-IIA), a fat-soluble diterpene quinone extracted from Salvia miltiorrhiza, is widely recognized for its multiple pharmacological properties, including anti-inflammatory, antioxidant, anti-fibrotic, and anti-tumor effects. Recent studies have highlighted its great potential in treating bone metabolic disorders, especially osteoporosis and bone damage repair. Bone health depends on the dynamic balance between osteoblast-mediated bone formation and osteoclast-mediated bone resorption. Disruption of this balance can lead to diseases such as osteoporosis, which is often diagnosed after a fracture, seriously affecting the quality of life and increasing the medical burden. Early identification of high-risk groups and appropriate treatment are essential for preventing fracture recurrence. Studies have shown that T-IIA can promote osteoblast differentiation and inhibit osteoclast activity, targeting key signaling pathways such as NF-\u03baB, PI3K\/Akt, and Wnt\/\u03b2-catenin, all of which are closely related to bone metabolism. T-IIA has a dual role in regulating bone formation and bone resorption, making it a potential drug for the treatment of osteoporosis. In addition, T-IIA has neuroprotective, hepatic, renal, cardiac, and cerebral effects, which enhance its therapeutic effect. Despite the remarkable efficacy of T-IIA, its clinical application is limited due to poor solubility and low bioavailability. Recent advances in drug delivery systems, such as liposome formulations and nanocarriers, have improved their pharmacokinetics, increased absorption rate, and bioavailability. Combination therapy with growth factors or stem cells can further enhance its efficacy. Future studies should focus on optimizing the delivery system of T-IIA and exploring its combined application with other therapeutic strategies to expand its clinical application range.<\/jats:p>","DOI":"10.3390\/ph18091338","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T08:22:34Z","timestamp":1757406154000},"page":"1338","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Pharmacological Effects and Mechanisms of Tanshinone IIA in Bone Injury Repair"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8844-3392","authenticated-orcid":false,"given":"Weijian","family":"Hu","sequence":"first","affiliation":[{"name":"Medical College, Northwest University, Xi\u2019an 710127, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yameng","family":"Si","sequence":"additional","affiliation":[{"name":"School of Stomatology, Xuzhou Medical University, Xuzhou 221004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Wen","sequence":"additional","affiliation":[{"name":"College of Life Sciences, Northwest University, Xi\u2019an 710127, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duan","family":"Lin","sequence":"additional","affiliation":[{"name":"College of Life Sciences, Northwest University, Xi\u2019an 710127, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Yu","sequence":"additional","affiliation":[{"name":"College of Life Sciences, Northwest University, Xi\u2019an 710127, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7132-5609","authenticated-orcid":false,"given":"Xin","family":"Xie","sequence":"additional","affiliation":[{"name":"College of Life Sciences, Northwest University, Xi\u2019an 710127, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5960-9174","authenticated-orcid":false,"given":"Jiabin","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Stomatology, Xuzhou Medical University, Xuzhou 221004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/GRF.0000000000000572","article-title":"Bone Health and Osteoporosis Prevention and Treatment","volume":"63","author":"Robinson","year":"2020","journal-title":"Clin. Obs. Gynecol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician\u2019s guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff","year":"2022","journal-title":"Osteoporos. Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3803\/EnM.2021.301","article-title":"Long-Term Treatment of Postmenopausal Osteoporosis","volume":"36","author":"Brown","year":"2021","journal-title":"Endocrinol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ecl.2021.03.009","article-title":"Postmenopausal Osteoporosis: Latest Guidelines","volume":"50","author":"Camacho","year":"2021","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Ye, Z., Liu, Y., Song, J., Gao, Y., Fang, H., Hu, Z., Zhang, M., Liao, W., Cui, L., and Liu, Y. (2023). Expanding the therapeutic potential of Salvia miltiorrhiza: A review of its pharmacological applications in musculoskeletal diseases. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1276038"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13018-025-05483-y","article-title":"Mechanisms and new advances in the efficacy of plant active ingredients in tendon-bone healing","volume":"20","author":"Li","year":"2025","journal-title":"J. Orthop. Surg. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.2147\/DDDT.S266911","article-title":"Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases","volume":"14","author":"Guo","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Chen, Z., Feng, H., Peng, C., Zhang, Z., Yuan, Q., Gao, H., Tang, S., and Xie, C. (2023). Renoprotective Effects of Tanshinone IIA: A Literature Review. Molecules, 28.","DOI":"10.3390\/molecules28041990"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Liu, Q., Li, X., and Luo, Y. (2024). Tanshinone IIA delays liver aging by modulating oxidative stress. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1434024"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ekeuku, S.O., Pang, K.L., and Chin, K.Y. (2021). The Skeletal Effects of Tanshinones: A Review. Molecules, 26.","DOI":"10.3390\/molecules26082319"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Zeng, H., Su, S., Xiang, X., Sha, X., Zhu, Z., Wang, Y., Guo, S., Yan, H., Qian, D., and Duan, J. (2017). Comparative Analysis of the Major Chemical Constituents in Salvia miltiorrhiza Roots, Stems, Leaves and Flowers during Different Growth Periods by UPLC-TQ-MS\/MS and HPLC-ELSD Methods. Molecules, 22.","DOI":"10.3390\/molecules22050771"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"778847","DOI":"10.3389\/fphar.2021.778847","article-title":"Recent Research Progress (2015\u20132021) and Perspectives on the Pharmacological Effects and Mechanisms of Tanshinone IIA","volume":"12","author":"Zhong","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Zhou, Z.Y., Zhao, W.R., Zhang, J., Chen, X.L., and Tang, J.Y. (2019). Sodium tanshinone IIA sulfonate: A review of pharmacological activity and pharmacokinetics. Biomed. Pharmacother., 118.","DOI":"10.1016\/j.biopha.2019.109362"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Xu, J., Zhang, C., Shi, X., Li, J., Liu, M., Jiang, W., and Fang, Z. (2019). Efficacy and Safety of Sodium Tanshinone IIA Sulfonate Injection on Hypertensive Nephropathy: A Systematic Review and Meta-Analysis. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.01542"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.2147\/DDDT.S494555","article-title":"Pharmacological Mechanisms of Cryptotanshinone: Recent Advances in Cardiovascular, Cancer, and Neurological Disease Applications","volume":"18","author":"Zheng","year":"2024","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Bi, Z., Wang, Y., and Zhang, W. (2021). A comprehensive review of tanshinone IIA and its derivatives in fibrosis treatment. Biomed. Pharmacother., 137.","DOI":"10.1016\/j.biopha.2021.111404"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Xiao, Z., Liu, W., Mu, Y.P., Zhang, H., Wang, X.N., Zhao, C.Q., Chen, J.M., and Liu, P. (2020). Pharmacological Effects of Salvianolic Acid B Against Oxidative Damage. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.572373"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"He, G., Chen, G., Liu, W., Ye, D., Liu, X., Liang, X., and Song, J. (2023). Salvianolic Acid B: A Review of Pharmacological Effects, Safety, Combination Therapy, New Dosage Forms, and Novel Drug Delivery Routes. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15092235"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Xing, L., Tan, Z.R., Cheng, J.L., Huang, W.H., Zhang, W., Deng, W., Yuan, C.S., and Zhou, H.H. (2017). Bioavailability and pharmacokinetic comparison of tanshinones between two formulations of Salvia miltiorrhiza in healthy volunteers. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-02747-4"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s13318-022-00777-6","article-title":"Pharmacokinetic Comparison of Nine Bioactive Compounds of Guanxinshutong Capsule in Normal and Acute Myocardial Infarction Rats","volume":"47","author":"Yang","year":"2022","journal-title":"Eur. J. Drug. Metab. Pharmacokinet."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Bhadoriya, A., Shah, P.A., Shrivastav, P.S., Bharwad, K.D., and Singhal, P. (2019). Determination of terbinafine in human plasma using UPLC-MS\/MS: Application to a bioequivalence study in healthy subjects. Biomed. Chromatogr., 33.","DOI":"10.1002\/bmc.4543"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/bdd.2213","article-title":"Comparative pharmacokinetics and tissue distribution of cryptotanshinone, tanshinone IIA, dihydrotanshinone I, and tanshinone I after oral administration of pure tanshinones and liposoluble extract of Salvia miltiorrhiza to rats","volume":"41","author":"Wang","year":"2020","journal-title":"Biopharm. Drug Dispos."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"119598","DOI":"10.1016\/j.ijpharm.2020.119598","article-title":"Enhanced oral bioavailability of Tanshinone IIA using lipid nanocapsules: Formulation, in-vitro appraisal and pharmacokinetics","volume":"586","author":"Ashour","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/jphp.12423","article-title":"Improvement in oral bioavailability and dissolution of tanshinone IIA by preparation of solid dispersions with porous silica","volume":"67","author":"Yan","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/21691401.2018.1431651","article-title":"Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA","volume":"46","author":"Li","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Song, L., Zhang, W., Tang, S.Y., Luo, S.M., Xiong, P.Y., Liu, J.Y., Hu, H.C., Chen, Y.Q., Jia, B., and Yan, Q.H. (2024). Natural products in traditional Chinese medicine: Molecular mechanisms and therapeutic targets of renal fibrosis and state-of-the-art drug delivery systems. Biomed. Pharmacother., 170.","DOI":"10.1016\/j.biopha.2023.116039"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1080\/10717544.2022.2072543","article-title":"Multifunctional icariin and tanshinone IIA co-delivery liposomes with potential application for Alzheimer\u2019s disease","volume":"29","author":"Wang","year":"2022","journal-title":"Drug Deliv."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"8013","DOI":"10.2147\/IJN.S331690","article-title":"Modified Lipid Nanocapsules for Targeted Tanshinone IIA Delivery in Liver Fibrosis","volume":"16","author":"Khalifa","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"102797","DOI":"10.1016\/j.nano.2024.102797","article-title":"The nanocrystal-loaded liposome of tanshinone IIA with high drug loading and stability towards efficient liver fibrosis reversion","volume":"63","author":"Cai","year":"2025","journal-title":"Nanomedicine"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"13621","DOI":"10.3390\/ijms131013621","article-title":"Tanshinones: Sources, pharmacokinetics and anti-cancer activities","volume":"13","author":"Zhang","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3892\/mmr.2013.1290","article-title":"Tanshinone IIA inhibits the growth of pancreatic cancer BxPC-3 cells by decreasing protein expression of TCTP, MCL-1 and Bcl-xL","volume":"7","author":"Huang","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13020-016-0083-z","article-title":"Kinetics of cytochrome P450 enzymes for metabolism of sodium tanshinone IIA sulfonate in vitro","volume":"11","author":"Huang","year":"2016","journal-title":"Chin. Med."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Liang, S., Wang, Z., Yuan, J., Zhang, J., Dai, X., Qin, F., Zhang, J., and Sun, Y. (2019). Rapid Identification of Tanshinone IIA Metabolites in an Amyloid-\u03b2(1\u201342) Induced Alzherimer\u2019s Disease Rat Model using UHPLC-Q-Exactive Qrbitrap Mass Spectrometry. Molecules, 24.","DOI":"10.3390\/molecules24142584"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4103\/0973-1296.137369","article-title":"Pharmacokinetics and tissue distribution study of tanshinone IIA after oral administration of Bushen Huoxue Qubi granules to rats with blood stasis syndrome","volume":"10","author":"Wang","year":"2014","journal-title":"Pharmacogn. Mag."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00210-024-03351-w","article-title":"Pharmacological impacts of tanshinone on osteogenesis and osteoclastogenesis: A review","volume":"398","author":"Sudha","year":"2025","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev. Cell"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"de Molon, R.S. (2025). Therapeutic Potential of Tanshinones in Osteolytic Diseases: From Molecular and Cellular Pathways to Preclinical Models. Dent. J., 13.","DOI":"10.3390\/dj13070309"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"104784","DOI":"10.1016\/j.jff.2021.104784","article-title":"Tanshinone IIA attenuates polyethylene-induced osteolysis in a mouse model: The key role of miR-155-5p\/FOXO3 axis","volume":"87","author":"Li","year":"2021","journal-title":"J. Funct. Foods"},{"key":"ref_39","first-page":"13695","article-title":"Tanshinone IIA blocks dexamethasone-induced apoptosis in osteoblasts through inhibiting Nox4-derived ROS production","volume":"8","author":"Li","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2024.13301","article-title":"Tanshinone IIA promotes osteogenic differentiation potential and suppresses adipogenic differentiation potential of bone marrow mesenchymal stem cells","volume":"30","author":"Wang","year":"2024","journal-title":"Mol. Med. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s13018-024-04793-x","article-title":"Local Application of Tanshinone IIA protects mesenchymal stem cells from apoptosis and promotes fracture healing in ovariectomized mice","volume":"19","author":"Cheng","year":"2024","journal-title":"J. Orthop. Surg. Res."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Li, X., Yang, X., Liu, Z., Liu, H., Lv, H., Li, X., Xu, X., and Shen, Y. (2025). Tanshinone I IA Reverses Osteogenic Differentiation of Bone Marrow Mesenchymal Stromal Cells Impaired by Glucocorticoids via the ERK1\/2-CREB Signaling Pathway. Chem. Biol. Drug Des., 105.","DOI":"10.1111\/cbdd.70069"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Xu, J., Zhi, X., Zhang, Y., and Ding, R. (2024). Tanshinone IIA alleviates IL-1\u03b2-induced chondrocyte apoptosis and inflammation by regulating FBXO11 expression. Clinics, 79.","DOI":"10.1016\/j.clinsp.2024.100365"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Sun, J., Chen, W., Zhou, Z., Chen, X., Zuo, Y., He, J., and Liu, H. (2023). Tanshinone IIA Facilitates Efficient Cartilage Regeneration under Inflammatory Factors Caused Stress via Upregulating LncRNA NEAT1_2. Biomedicines, 11.","DOI":"10.3390\/biomedicines11123291"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Li, H.Z., Han, D., Ao, R.F., Cai, Z.H., Zhu, G.Z., Wu, D.Z., Gao, J.W., Zhuang, J.S., Tu, C., and Zhao, K. (2024). Tanshinone IIA attenuates osteoarthritis via inhibiting aberrant angiogenesis in subchondral bone. Arch. Biochem. Biophys., 753.","DOI":"10.1016\/j.abb.2024.109904"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000505493","article-title":"Tanshinone IIA Ameliorates Inflammation Response in Osteoarthritis via Inhibition of miR-155\/FOXO3 Axis","volume":"106","author":"Zhou","year":"2021","journal-title":"Pharmacology"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Feng, M., Peng, H., Yao, R., Zhang, Z., Mao, G., Yu, H., and Qiu, Y. (2020). Inhibition of cellular communication network factor 1 (CCN1)-driven senescence slows down cartilage inflammaging and osteoarthritis. Bone, 139.","DOI":"10.1016\/j.bone.2020.115522"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12974-020-01981-4","article-title":"Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE\/NF-\u03baB signaling pathway in vivo and in vitro","volume":"17","author":"Ding","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.rvsc.2021.03.004","article-title":"Tanshinone IIA exhibits anti-inflammatory and antioxidative effects in LPS-stimulated bovine endometrial epithelial cells by activating the Nrf2 signaling pathway","volume":"136","author":"Fu","year":"2021","journal-title":"Res. Vet. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Yang, L., Zhou, G., Liu, J., Song, J., Zhang, Z., Huang, Q., and Wei, F. (2021). Tanshinone I and Tanshinone IIA\/B attenuate LPS-induced mastitis via regulating the NF-\u03baB. Biomed. Pharmacother., 137.","DOI":"10.1016\/j.biopha.2021.111353"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Carpi, S., Quarta, S., Doccini, S., Saviano, A., Marigliano, N., Polini, B., Massaro, M., Carluccio, M.A., Calabriso, N., and Wabitsch, M. (2023). Tanshinone IIA and Cryptotanshinone Counteract Inflammation by Regulating Gene and miRNA Expression in Human SGBS Adipocytes. Biomolecules, 13.","DOI":"10.3390\/biom13071029"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/s41401-020-00535-x","article-title":"Tanshinone IIA prevents LPS-induced inflammatory responses in mice via inactivation of succinate dehydrogenase in macrophages","volume":"42","author":"Liu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2174\/1381612828666211224152440","article-title":"Sodium Tanshinone IIA Sulfonate Improves Adverse Ventricular Remodeling Post-MI by Reducing Myocardial Necrosis, Modulating Inflammation, and Promoting Angiogenesis","volume":"28","author":"Zhang","year":"2022","journal-title":"Curr. Pharm. Des."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Li, F., Zhao, S., Fang, Q., Qiao, Z., Meng, Y., Jin, Q., Zong, L., Shui, L., Chen, S., and Han, H. (2025). Tanshinone IIA improved psychological stress-induced embryo implantation disorders by inhibiting GC\/GR signaling and promoting angiogenesis. Phytomedicine, 144.","DOI":"10.1016\/j.phymed.2025.156946"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Wang, X., and Wu, C. (2022). Tanshinone IIA improves cardiac function via regulating miR-499\u20135p dependent angiogenesis in myocardial ischemic mice. Microvasc. Res., 143.","DOI":"10.1016\/j.mvr.2022.104399"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3892\/etm.2021.10556","article-title":"Sodium tanshinone IIA sulfonate ameliorates cerebral ischemic injury through regulation of angiogenesis","volume":"22","author":"Xu","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Lou, G., Hu, W., Wu, Z., Xu, H., Yao, H., Wang, Y., Huang, Q., Wang, B., Wen, L., and Gong, D. (2020). Tanshinone II A attenuates vascular remodeling through klf4 mediated smooth muscle cell phenotypic switching. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-70887-1"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Li, H., Hu, P., Zou, Y., Yuan, L., Xu, Y., Zhang, X., Luo, X., and Zhang, Z. (2023). Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1071415"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Li, Q., Huang, D., Liao, W., Su, X., Li, J., Zhang, J., Fang, M., and Liu, Y. (2024). Tanshinone IIA regulates CCl4 induced liver fibrosis in C57BL\/6J mice via the PI3K\/Akt and Nrf2\/HO-1 signaling pathways. J. Biochem. Mol. Toxicol., 38.","DOI":"10.1002\/jbt.23648"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"114465","DOI":"10.1016\/j.intimp.2025.114465","article-title":"Tanshinone IIA alleviate atherosclerosis and hepatic steatosis via down-regulation of MAPKs\/NF-\u03baB signaling pathway","volume":"152","author":"Zhang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.4081\/ejh.2025.4218","article-title":"Tanshinone IIA attenuates hepatic stellate cell activation, oxidative stress, and liver fibrosis by inhibiting YAP signaling","volume":"69","author":"Wang","year":"2025","journal-title":"Eur. J. Histochem."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Qin, C., Liu, S., Zhou, S., Xia, X., Hu, J., Yu, Y., and Ma, D. (2023). Tanshinone IIA promotes vascular normalization and boosts Sorafenib\u2019s anti-hepatoma activity via modulating the PI3K-AKT pathway. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1189532"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"119169","DOI":"10.1016\/j.jep.2024.119169","article-title":"Tanshinone IIA, a component of Salvia miltiorrhiza Bunge, attenuated sepsis-induced liver injury via the SIRT1\/Sestrin2\/HO-1 signaling pathway","volume":"340","author":"Tian","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"116667","DOI":"10.1016\/j.jep.2023.116667","article-title":"Tanshinone IIA mediates protection from diabetes kidney disease by inhibiting oxidative stress induced pyroptosis","volume":"316","author":"Wu","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.2147\/DMSO.S464015","article-title":"Tanshinone IIA Promoted Autophagy and Inhibited Inflammation to Alleviate Podocyte Injury in Diabetic Nephropathy","volume":"17","author":"Li","year":"2024","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"111348","DOI":"10.1016\/j.cellsig.2024.111348","article-title":"Activation of SIRT3 by Tanshinone IIA ameliorates renal fibrosis by suppressing the TGF-\u03b2\/TSP-1 pathway and attenuating oxidative stress","volume":"122","author":"Fan","year":"2024","journal-title":"Cell. Signal."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1002\/fsn3.2998","article-title":"Tanshinone IIA improves diabetes-induced renal fibrosis by regulating the miR-34-5p\/Notch1 axis","volume":"10","author":"Zhang","year":"2022","journal-title":"Food Sci. Nutr."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/tox.23511","article-title":"Tanshinone IIA prevents acetaminophen-induced nephrotoxicity through the activation of the Nrf2-Mrp2\/4 pathway in mice","volume":"37","author":"Zhang","year":"2022","journal-title":"Env. Toxicol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Xu, L., Xu, Y., Zhu, Z., Gu, H., Chen, C., and Chen, J. (2021). Tanshinone IIA attenuates renal injury during hypothermic preservation via the MEK\/ERK1\/2\/GSK-3\u03b2 pathway. BMC Complement. Med. Ther., 21.","DOI":"10.1186\/s12906-021-03427-7"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijmm.2023.5312","article-title":"Tanshinone IIA confers protection against myocardial ischemia\/reperfusion injury by inhibiting ferroptosis and apoptosis via VDAC1","volume":"52","author":"Hu","year":"2023","journal-title":"Int. J. Mol. Med."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Chai, R., Ye, Z., Xue, W., Shi, S., Wei, Y., Hu, Y., and Wu, H. (2023). Tanshinone IIA inhibits cardiomyocyte pyroptosis through TLR4\/NF-\u03baB p65 pathway after acute myocardial infarction. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1252942"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Yan, N., Xiao, C., Wang, X., Xu, Z., and Yang, J. (2022). Tanshinone IIA from Salvia miltiorrhiza exerts anti-fibrotic effects on cardiac fibroblasts and rat heart tissues by suppressing the levels of pro-fibrotic factors: The key role of miR-618. J. Food Biochem., 46.","DOI":"10.1111\/jfbc.14078"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2021.12043","article-title":"Tanshinone IIA attenuates heart failure via inhibiting oxidative stress in myocardial infarction rats","volume":"23","author":"Chen","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Li, D., Yang, Z., Gao, S., Zhang, H., and Fan, G. (2022). Tanshinone IIA ameliorates myocardial ischemia\/reperfusion injury in rats by regulation of NLRP3 inflammasome activation and Th17 cells differentiation. Acta Cir. Bras., 37.","DOI":"10.1590\/acb370701"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"8304","DOI":"10.1039\/D2FO00710J","article-title":"Tanshinone IIA protected against lipopolysaccharide-induced brain injury through the protective effect of the blood-brain barrier and the suppression of oxidant stress and inflammatory response","volume":"13","author":"Wang","year":"2022","journal-title":"Food Funct."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"7459054","DOI":"10.1155\/2024\/7459054","article-title":"Tanshinone IIA Alleviates Traumatic Brain Injury by Reducing Ischemia-Reperfusion via the miR-124-5p\/FoxO1 Axis","volume":"2024","author":"Su","year":"2024","journal-title":"Mediat. Inflamm."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Song, Z., Feng, J., Zhang, Q., Deng, S., Yu, D., Zhang, Y., and Li, T. (2021). Tanshinone IIA Protects Against Cerebral Ischemia Reperfusion Injury by Regulating Microglial Activation and Polarization via NF-\u03baB Pathway. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.641848"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1142\/S0192415X22500781","article-title":"Tanshinone IIA Microemulsion Protects against Cerebral Ischemia Reperfusion Injury via Regulating H3K18ac and H4K8ac In Vivo and In Vitro","volume":"50","author":"Ma","year":"2022","journal-title":"Am. J. Chin. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"116772","DOI":"10.1016\/j.jep.2023.116772","article-title":"The protective effect of an extract of Salvia miltiorrhiza Bunge (Danshen) on cerebral ischemic injury in animal models: A systematic review and meta-analysis","volume":"317","author":"Xie","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00210-023-02476-8","article-title":"Tanshinone-IIA mediated neuroprotection by modulating neuronal pathways","volume":"396","author":"Sherawat","year":"2023","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Liu, X.Q., Hu, T., Wu, G.L., Qiao, L.J., Cai, Y.F., Wang, Q., and Zhang, S.J. (2024). Tanshinone IIA, the key compound in Salvia miltiorrhiza, improves cognitive impairment by upregulating A\u03b2-degrading enzymes in APP\/PS1 mice. Int. J. Biol. Macromol., 254.","DOI":"10.1016\/j.ijbiomac.2023.127923"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.brainresbull.2020.08.019","article-title":"Tanshinone IIA suppresses lipopolysaccharide-induced neuroinflammatory responses through NF-\u03baB\/MAPKs signaling pathways in human U87 astrocytoma cells","volume":"164","author":"Jin","year":"2020","journal-title":"Brain Res. Bull."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3892\/mmr.2014.2254","article-title":"Tanshinone IIA reduces the risk of Alzheimer\u2019s disease by inhibiting iNOS, MMP-2 and NF-\u03baBp65 transcription and translation in the temporal lobes of rat models of Alzheimer\u2019s disease","volume":"10","author":"Jiang","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Geng, L., Liu, W., and Chen, Y. (2019). Tanshinone IIA attenuates A\u03b2-induced neurotoxicity by down-regulating COX-2 expression and PGE2 synthesis via inactivation of NF-\u03baB pathway in SH-SY5Y cells. J. Biol. Res., 26.","DOI":"10.1186\/s40709-019-0102-1"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"16065","DOI":"10.1038\/cddiscovery.2016.65","article-title":"Simultaneous induction of apoptosis and necroptosis by Tanshinone IIA in human hepatocellular carcinoma HepG2 cells","volume":"2","author":"Lin","year":"2016","journal-title":"Cell Death Discov."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3892\/ijo.2014.2471","article-title":"Tanshinone IIA induces cytochrome c-mediated caspase cascade apoptosis in A549 human lung cancer cells via the JNK pathway","volume":"45","author":"Zhang","year":"2014","journal-title":"Int. J. Oncol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Huang, S.T., Huang, C.C., Huang, W.L., Lin, T.K., Liao, P.L., Wang, P.W., Liou, C.W., and Chuang, J.H. (2017). Tanshinone IIA induces intrinsic apoptosis in osteosarcoma cells both in vivo and in vitro associated with mitochondrial dysfunction. Sci. Rep., 7.","DOI":"10.1038\/srep40382"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Fang, Z., Zhang, M., Liu, J.N., Zhao, X., Zhang, Y.Q., and Fang, L. (2020). Tanshinone IIA: A Review of its Anticancer Effects. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.611087"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"6285","DOI":"10.3892\/mmr.2017.7340","article-title":"Articular cartilage degradation is prevented by tanshinone IIA through inhibiting apoptosis and the expression of inflammatory cytokines","volume":"16","author":"Jia","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.taap.2019.05.014","article-title":"Tanshinone prevents alveolar bone loss in ovariectomized osteoporosis rats by up-regulating phosphoglycerate dehydrogenase","volume":"376","author":"Wang","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/13880209.2020.1738502","article-title":"Inhibition of tanshinone IIA on renin activity protected against osteoporosis in diabetic mice","volume":"58","author":"Zhang","year":"2020","journal-title":"Pharm. Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"109575","DOI":"10.1016\/j.ecoenv.2019.109575","article-title":"Recovery of chicken growth plate by Tanshinone\u2161A through wnt\/\u03b2-catenin pathway in thiram-induced Tibial Dyschondroplasia","volume":"183","author":"Yang","year":"2019","journal-title":"Ecotoxicol. Env. Saf."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13020-023-00765-1","article-title":"Tanshinone IIA inhibits osteoclastogenesis in rheumatoid arthritis via LDHC-regulated ROS generation","volume":"18","author":"Peng","year":"2023","journal-title":"Chin. Med."},{"key":"ref_94","first-page":"1457","article-title":"Tanshinone IIA attenuates osteoclastogenesis in ovariectomized mice by inactivating NF-kB and Akt signaling pathways","volume":"10","author":"Cheng","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Wang, Y., Liu, L., Qu, Z., Wang, D., Huang, W., Kong, L., and Yan, L. (2022). Tanshinone Ameliorates Glucocorticoid-Induced Bone Loss via Activation of AKT1 Signaling Pathway. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.878433"},{"key":"ref_96","first-page":"4461","article-title":"Tanshinone IIA protects against polyethylene particle-induced osteolysis response in a mouse calvarial model","volume":"11","author":"Yao","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00210-015-1154-x","article-title":"Effects of Tanshinone IIA on osteogenic differentiation of mouse bone marrow mesenchymal stem cells","volume":"388","author":"Qian","year":"2015","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_98","first-page":"340","article-title":"Tanshinone IIA promotes osteogenic differentiation of human periodontal ligament stem cells via ERK1\/2-dependent Runx2 induction","volume":"11","author":"Liu","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/emm.2006.31","article-title":"Tanshinone IIA inhibits osteoclast differentiation through down-regulation of c-Fos and NFATc1","volume":"38","author":"Kwak","year":"2006","journal-title":"Exp. Mol. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"106042","DOI":"10.1016\/j.ejps.2021.106042","article-title":"Influence of release rate, dose and co-administration on pharmacokinetics, pharmacodynamics and PK-PD relationship of tanshinone IIA and tanshinol","volume":"168","author":"Li","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Wang, D., Zhang, S., Tang, H., Jiang, C., Wang, B., and Liu, J. (2019). Development of sustained-release pellets to modulate the in vivo processes of the main active components of Danshen: A pharmacokinetic and pharmacodynamic evaluation. Phytomedicine, 58.","DOI":"10.1016\/j.phymed.2018.12.016"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"El-Moslemany, R.M., El-Kamel, A.H., Allam, E.A., Khalifa, H.M., Hussein, A., and Ashour, A.A. (2022). Tanshinone IIA loaded bioactive nanoemulsion for alleviation of lipopolysaccharide induced acute lung injury via inhibition of endothelial glycocalyx shedding. Biomed. Pharmacother., 155.","DOI":"10.1016\/j.biopha.2022.113666"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"125228","DOI":"10.1016\/j.ijpharm.2025.125228","article-title":"Biomimetic metal-phenolic nanocarrier for co-delivery of multiple phytomedical bioactive components for anti-atherosclerotic therapy","volume":"671","author":"Chen","year":"2025","journal-title":"Int. J. Pharm."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Chen, X., Zhou, Q., Wang, B., Feng, D., Jiang, R., and Wang, X. (2024). Efficacy and safety of tanshinone IIA in combination with mesalazine in the treatment of ulcerative colitis: A Systematic review and meta-analysis. BMC Gastroenterol., 24.","DOI":"10.1186\/s12876-024-03496-1"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.toxlet.2022.12.002","article-title":"Chemical Stability and Bioactivity of tanshinone I, tanshinone IIA, cryptotanshinone and dihydrotanshinone in in vitro test systems","volume":"375","author":"Roth","year":"2023","journal-title":"Toxicol. Lett."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Zhou, H., Zhao, Y., Peng, W., Han, W., Wang, Z., Ren, X., Wang, D., Pan, G., Lin, Q., and Wang, X. (2021). Effect of Sodium Tanshinone IIA Sulfonate Injection on Blood Lipid in Patients With Coronary Heart Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.770746"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Morton, J.S., Andersson, I.J., Cheung, P.-Y., Baker, P., Davidge, S.T., and Torrens, C. (2015). The vascular effects of sodium tanshinone IIA sulphonate in rodent and human pregnancy. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0121897"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Wu, X., Fan, M., Wei, S., Guo, D., and Ong, H.T. (2023). The efficacy and safety of sodium tanshinone \u2161A sulfonate injection in the treatment of unstable angina pectoris: A systematic review and meta-analysis. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0290841"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11655-017-2424-x","article-title":"Sodium Tanshinone II A Sulfonate Injection as Adjuvant Treatment for Unstable Angina Pectoris: A Meta-Analysis of 17 Randomized Controlled Trials","volume":"24","author":"Tan","year":"2018","journal-title":"Chin. J. Integr. Med."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/9\/1338\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:41:07Z","timestamp":1760035267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/9\/1338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":109,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["ph18091338"],"URL":"https:\/\/doi.org\/10.3390\/ph18091338","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]}}}